NCT05913388 GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT05909904 A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05902988 A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05901545 Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer Status RECRUITING Phase PHASE1
NCT05889091 A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment Status RECRUITING Phase NA
NCT05879484 Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS Status WITHDRAWN Phase PHASE1/PHASE2
NCT05877599 A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Status RECRUITING Phase PHASE1
NCT05867303 A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05859074 A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer Status RECRUITING Phase PHASE1
NCT05858736 Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05854823 The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR Status RECRUITING Phase NA
NCT05821751 The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors Status RECRUITING Phase NA
NCT05793151 Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy Status RECRUITING Phase NA
NCT05787535 HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor Status UNKNOWN Phase PHASE1
NCT05784688 Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05784012 Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05747625 (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase PHASE1
NCT05726370 Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC Status RECRUITING Phase PHASE2
NCT05714553 NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours Status TERMINATED Phase PHASE1/PHASE2